Myocardial Ischemia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Spanish Biotech Gets ?2.4M to Spot Myocardial Infarction Before it's Too Late - Labiotech.eu (blog)



Labiotech.eu (blog)
 
Spanish Biotech Gets ?2.4M to Spot Myocardial Infarction Before it's Too Late 
Labiotech.eu (blog)
GlyCardial Diagnostics believes it has the technology to prevent premature myocardial infarctions, 80% of which are preventable. Barcelona-based GlyCardial Diagnostics is a biotech, which spun-out from the Catalan Institute of Cardiovascular Science.

 


RESULTS FROM THE PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED ... - Nasdaq



RESULTS FROM THE PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED ... 
Nasdaq
Furthermore, patients are at risk of acute thromboembolic complications (e.g. stroke, myocardial infarction) and of recurrence of disease. Some patients are refractory to therapy1, which is associated with a poor prognosis for survival of an acute ...

and more » 


FDA expands approval of Sutent to reduce the risk of kidney cancer returning - FDA.gov



WHBL Sheboygan
 
FDA expands approval of Sutent to reduce the risk of kidney cancer returning 
FDA.gov
Severe side effects of Sutent include severe liver damage (hepatotoxicity), heart failure (low left ventricular ejection fraction), heart attack (myocardial ischemia/infarction), abnormal health rhythm (prolonged QT intervals/Torsade de Pointes ...
FDA Approves Sunitinib for Adjuvant Treatment of RCC Renal and Urology News
FDA approves Sutent to reduce risk for recurrent kidney cancer Healio

all 10 news articles » 


FAME 2: Stable Angina With Poor Flow Benefits From PCI - Medscape



Medscape
 
FAME 2: Stable Angina With Poor Flow Benefits From PCI 
Medscape
However, those studies were limited by including patients with minimal or no myocardial ischemia and used older PCI techniques," Fearon said at a briefing prior to presentation of the data in a late-breaking abstracts session at TCT 2017 here. FAME 2 ...

 


Myocardial Infarction - Pipeline Review, H2 2017; New Report Launched - Digital Journal



Myocardial Infarction - Pipeline Review, H2 2017; New Report Launched 
Digital Journal
Bangalore, India -- (SBWIRE) -- 11/14/2017 -- Myocardial Infarction - Pipeline Review, H2 2017, provides an overview of the Myocardial Infarction (Cardiovascular) pipeline landscape. Myocardial infarction is the irreversible necrosis of heart muscle ...

and more » 


HREVS: 3 procedures for multivessel CAD result in similar outcomes - Healio



HREVS: 3 procedures for multivessel CAD result in similar outcomes 
Healio
The rates of residual myocardial ischemia and MACCE were similar in patients with multivessel CAD who underwent PCI, CABG or hybrid revascularization, according to data presented at TCT 2017. Roman Tarasov, MD, PhD, head of the laboratory of ...

and more » 


Aggressive testing provides no benefit to patients in ER with chest pain - Washington University School of Medicine in St. Louis



Washington University School of Medicine in St. Louis
 
Aggressive testing provides no benefit to patients in ER with chest pain 
Washington University School of Medicine in St. Louis
The investigators evaluated data from 1,000 patients treated at nine medical centers across the country, including Washington University School of Medicine, that were a part of the Rule Out Myocardial Ischemia/Infarction by Computer Assisted Tomography ...

and more » 


Gout Drug Febuxostat (Uloric) Subject of FDA Safety Alert - Medscape - Medscape



Medscape
 
Gout Drug Febuxostat (Uloric) Subject of FDA Safety Alert - Medscape 
Medscape
Preliminary data from a safety study show an increased risk for heart-related deaths with febuxostat compared with allopurinol in patients with gout, the FDA ...

and more » 


For SAVR, Afternoon Tops Morning for Surgical Safety - MedPage Today



MedPage Today
 
For SAVR, Afternoon Tops Morning for Surgical Safety 
MedPage Today
Clock genes may play a role in how well a patient is able to tolerate myocardial ischemia?reperfusion during surgical aortic valve replacement (SAVR), with potential implications for timing of surgery, a series of French studies showed. A single-center ...

 


BioCardia, Inc. Reports Third Quarter 2017 Financial Results and ... - Business Wire (press release)



BioCardia, Inc. Reports Third Quarter 2017 Financial Results and ... 
Business Wire (press release)
BioCardiaŽ, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reporte.

and more »